| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.27505 |
| P698 | PubMed publication ID | 22362391 |
| P50 | author | Alexander B Philipp | Q62064966 |
| P2093 | author name string | Andreas Jung | |
| Jens Neumann | |||
| Frank T Kolligs | |||
| Andreas Herbst | |||
| Dorothea Nagel | |||
| Fritz Spelsberg | |||
| Petra Stieber | |||
| Rolf Lamerz | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| colorectal cancer | Q188874 | ||
| P1104 | number of pages | 12 | |
| P304 | page(s) | 2308-2319 | |
| P577 | publication date | 2012-03-27 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Prognostic role of methylated free circulating DNA in colorectal cancer | |
| P478 | volume | 131 |
| Q26779222 | "Liquid biopsy"-ctDNA detection with great potential and challenges |
| Q39159559 | A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA. |
| Q38122618 | Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations |
| Q47162128 | Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma |
| Q58114470 | Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review |
| Q93200678 | Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review |
| Q33611481 | Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer |
| Q90162252 | DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types |
| Q37055333 | DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer |
| Q34487177 | Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers |
| Q49663292 | Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives |
| Q28071714 | Epigenetics in diagnosis of colorectal cancer |
| Q35726371 | Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update |
| Q41050138 | Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers |
| Q35111866 | Examination of whole blood DNA methylation as a potential risk marker for gastric cancer |
| Q52719002 | Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC). |
| Q92242802 | High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib |
| Q87660488 | Intravenous administration of a single-dose free-circulating DNA of colitic origin improves severe murine DSS-colitis |
| Q58102470 | Liquid Biopsy in Gastrointestinal Cancers |
| Q26772077 | Methylated circulating tumor DNA in blood: power in cancer prognosis and response |
| Q41080927 | Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer |
| Q37298333 | Methylation of serum SST gene is an independent prognostic marker in colorectal cancer |
| Q92369113 | PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis |
| Q54203378 | Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. |
| Q85302974 | Preconditioning with intravenous colitic cell-free DNA prevents DSS-colitis by altering TLR9-associated gene expression profile |
| Q52802632 | Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. |
| Q36277022 | Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review |
| Q35138892 | Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer |
| Q35533772 | Promoter hypermethylation profiling of distant breast cancer metastases |
| Q39051652 | Role of circulating free DNA in colorectal cancer |
| Q37242412 | Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet? |
| Q37015727 | The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis |
| Q39068458 | The clinical role of circulating free tumor DNA in gastrointestinal malignancy |
| Q38608560 | The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor? |
Search more.